Report overview
Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation.
This report contains market size and forecasts of Emerging Cancer Diagnostics in Global, including the following market information:
Global Emerging Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Emerging Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Men Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Emerging Cancer Diagnostics include Abbott Laboratories, Danaher, Agilent Technologies, AstraZeneca, BD, Biocept, Illumina, Luminex and NeoGenomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Emerging Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Emerging Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Men
Women
Global Emerging Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Blood Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Others
Global Emerging Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Emerging Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Emerging Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Danaher
Agilent Technologies
AstraZeneca
BD
Biocept
Illumina
Luminex
NeoGenomics
QIAGEN
Thermo Fisher Scientific
